homocysteine has been researched along with leuprolide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colao, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Sammartino, A; Sbano, FM; Zullo, F | 1 |
| Ferreira, RA; Ferriani, RA; Nogueira, AA; Rosa-e-Silva, AC; Rosa-E-Silva, JC; Vieira, CS | 1 |
2 trial(s) available for homocysteine and leuprolide
| Article | Year |
|---|---|
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene.
Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Leiomyoma; Leuprolide; Lipids; Middle Aged; Placebos; Premenopause; Raloxifene Hydrochloride; Triglycerides; Uterine Neoplasms; Vitamin B 12 | 2004 |
Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
Topics: Adult; Biomarkers; Cardiovascular System; Contraceptive Agents, Female; Endometriosis; Female; Homocysteine; Humans; Interleukin-6; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Pain; Pain Measurement; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |